Sanofi Invests EUR 300 Million in Joint Venture with Orano Med for Next-Generation Radioligand Therapies
Sanofi (EPA: SAN), a leading French pharmaceutical company, has entered into a strategic agreement with...
Antengene’s Xpovio Secures Expanded Access in South Korea for Multiple Myeloma Treatment
Antengene Corp., Ltd (HKG: 6996), a China-based biopharmaceutical company, has announced that it has received...
AbbVie’s Vyalev Wins FDA Approval as First Subcutaneous Levodopa Therapy for Advanced Parkinson’s
AbbVie (NYSE: ABBV), a leading pharmaceutical company based in the US, has received approval from...
Chengdu Drafts Comprehensive Policy to Stimulate Biomedical Industry Growth
The Chengdu Municipal Bureau of Economic and Information Technology has unveiled a draft proposal titled...
Chongqing Zhifei Biological’s EC Injection Receives Market Approval in Indonesia
Chongqing Zhifei Biological Co., Ltd (SHE: 300122), a leading biopharmaceutical company based in China, has...
Tencent Invests USD 30 Million in Early Cancer Detection Firm Insighta, Backed by Prenetics
Prenetics Global Limited (NASDAQ: PRE), a prominent health sciences company with operations in the US...
LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline
LaNova Medicines Ltd, a Shanghai-based developer of cancer therapies, has announced the successful completion of...
Abbott Laboratories Posts 9.4% Q3 Sales Growth, Driven by Medical Devices and Pharmaceuticals
Abbott Laboratories (NYSE: ABT), a U.S.-based healthcare giant, has reported its financial results for the...
Chengdu Baiyu Pharmaceutical Strikes Licensing Deal with Novartis for Unannounced Anti-Tumor Asset
Chengdu Baiyu Pharmaceutical Co., Ltd., a Chinese pharmaceutical company, has entered into a licensing agreement...
Cryofocus Medtech Partners with Guangzhou Medical University Hospital for Cryoballoon Ablation R&D
Cryofocus Medtech (Shanghai) Co., Ltd. (HKG: 6922), a Shanghai-based leader in cryoablation treatment, and the...
Kintor Pharmaceutical Initiates Phase II/III Trial for KX-826 Tincture 1.0% in Treating Male Androgenetic Alopecia
Kintor Pharmaceutical Ltd (HKG: 9939), a biopharmaceutical company based in China, has announced the commencement...
Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies
Novocure (NASDAQ: NVCR), a Swiss firm renowned for its pioneering Tumor Treating Fields (TTFields) cancer...
Servier and HUST Forge Partnership to Cultivate Innovative Therapies through SHINEDocs Program
French pharmaceutical company Servier has joined forces with Huazhong University of Science and Technology (HUST),...
Innovent Biologics’ Picankibart Achieves Positive Results in Phase II UC Study
Innovent Biologics, Inc. (HKG: 1801), a leading biopharmaceutical company based in China, has announced that...
Bayer AG Launches China Innovation Hub to Boost Local R&D and Global Integration
Bayer AG (ETR: BAYN), a German multinational pharmaceutical and life sciences giant, has announced the...
Lexicon Pharmaceuticals Strikes Licensing Deal with Viatris for Global Expansion of Sotagliflozin
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has entered into a licensing agreement with Viatris Inc. (NASDAQ:...
Johnson & Johnson’s Nipocalimab Shows Promise in Treating Adolescent Myasthenia Gravis in Phase II/III Trial
Johnson & Johnson (J&J, NYSE: JNJ), a US pharmaceutical giant, has reported encouraging outcomes from...
NHSA Standardizes NRDL Drug Purchases to Combat Prescription Fraud
The National Healthcare Security Administration (NHSA) has issued a notification aimed at standardizing the management...
Shanxi Province Announces Historic Drug Procurement Batch with 81 Products for 2024
On October 16, 2024, Shanxi Province’s drug procurement platform announced a notice regarding the submission...
Alphamab Oncology and CSPC Pharma’s KN026 Phase III Trial for Breast Cancer Gets NMPA Approval
Alphamab Oncology (HKG: 9966) and CSPC Pharma (HKG: 1093) have jointly announced that their Phase...